IOL CHEMICALS & PHARM. | LINCOLN PHAR | IOL CHEMICALS & PHARM./ LINCOLN PHAR |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | 14.0 | 96.8% | View Chart |
P/BV | x | 1.5 | 2.4 | 63.5% | View Chart |
Dividend Yield | % | 1.0 | 0.2 | 410.4% |
IOL CHEMICALS & PHARM. LINCOLN PHAR |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
LINCOLN PHAR Mar-23 |
IOL CHEMICALS & PHARM./ LINCOLN PHAR |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 380 | 141.3% | |
Low | Rs | 272 | 255 | 106.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 254.8 | 148.2% | |
Earnings per share (Unadj.) | Rs | 23.7 | 36.4 | 65.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 41.0 | 77.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 1.50 | 266.7% | |
Avg Dividend yield | % | 1.0 | 0.5 | 209.3% | |
Book value per share (Unadj.) | Rs | 256.8 | 250.9 | 102.4% | |
Shares outstanding (eoy) | m | 58.71 | 20.03 | 293.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.2 | 85.9% | |
Avg P/E ratio | x | 17.1 | 8.7 | 195.6% | |
P/CF ratio (eoy) | x | 12.8 | 7.7 | 165.4% | |
Price / Book Value ratio | x | 1.6 | 1.3 | 124.4% | |
Dividend payout | % | 16.9 | 4.1 | 409.5% | |
Avg Mkt Cap | Rs m | 23,743 | 6,358 | 373.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 932 | 180.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 5,103 | 434.5% | |
Other income | Rs m | 256 | 225 | 114.0% | |
Total revenues | Rs m | 22,427 | 5,328 | 420.9% | |
Gross profit | Rs m | 2,257 | 892 | 253.0% | |
Depreciation | Rs m | 462 | 92 | 503.6% | |
Interest | Rs m | 165 | 20 | 811.3% | |
Profit before tax | Rs m | 1,887 | 1,005 | 187.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 276 | 179.5% | |
Profit after tax | Rs m | 1,391 | 729 | 190.9% | |
Gross profit margin | % | 10.2 | 17.5 | 58.2% | |
Effective tax rate | % | 26.2 | 27.4 | 95.6% | |
Net profit margin | % | 6.3 | 14.3 | 43.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 3,911 | 247.2% | |
Current liabilities | Rs m | 5,025 | 962 | 522.6% | |
Net working cap to sales | % | 20.9 | 57.8 | 36.2% | |
Current ratio | x | 1.9 | 4.1 | 47.3% | |
Inventory Days | Days | 43 | 128 | 33.7% | |
Debtors Days | Days | 8 | 975 | 0.9% | |
Net fixed assets | Rs m | 11,017 | 2,454 | 448.9% | |
Share capital | Rs m | 587 | 200 | 293.1% | |
"Free" reserves | Rs m | 14,490 | 4,824 | 300.3% | |
Net worth | Rs m | 15,077 | 5,025 | 300.1% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 6,365 | 325.0% | |
Interest coverage | x | 12.5 | 50.5 | 24.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.8 | 133.7% | |
Return on assets | % | 7.5 | 11.8 | 63.9% | |
Return on equity | % | 9.2 | 14.5 | 63.6% | |
Return on capital | % | 13.6 | 20.4 | 66.7% | |
Exports to sales | % | 26.7 | 57.4 | 46.6% | |
Imports to sales | % | 0 | 2.0 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 2,931 | 202.3% | |
Imports (cif) | Rs m | NA | 100 | 0.0% | |
Fx inflow | Rs m | 5,930 | 2,931 | 202.3% | |
Fx outflow | Rs m | 6,052 | 100 | 6,040.9% | |
Net fx | Rs m | -122 | 2,831 | -4.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 393 | 311.4% | |
From Investments | Rs m | -1,200 | -366 | 327.5% | |
From Financial Activity | Rs m | -41 | -45 | 91.3% | |
Net Cashflow | Rs m | -18 | -19 | 97.8% |
Indian Promoters | % | 48.2 | 49.5 | 97.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 4.0 | 42.7% | |
FIIs | % | 1.4 | 3.9 | 35.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 50.5 | 102.7% | |
Shareholders | 130,003 | 31,375 | 414.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | LINCOLN PHAR | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.01% | 1.81% | 0.43% |
1-Month | 4.75% | 0.24% | 0.50% |
1-Year | -0.26% | 53.51% | 52.83% |
3-Year CAGR | -13.16% | 32.90% | 14.45% |
5-Year CAGR | 15.99% | 26.62% | 19.12% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the LINCOLN PHAR share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of LINCOLN PHAR the stake stands at 49.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of LINCOLN PHAR.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
LINCOLN PHAR paid Rs 1.5, and its dividend payout ratio stood at 4.1%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of LINCOLN PHAR.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the higher.